GR

Green Cross Holdings

A holding company in biopharma, diagnostics, consumer, and digital healthcare.

005250 | KO

Overview

Corporate Details

ISIN(s):
KR7005250006
LEI:
Country:
South Korea
Address:
경기 용인시 구성읍 동백리 (주)녹십자 303, 용인시

Description

Green Cross Holdings is a holding company operating as a global leader in the health industry. The company's business is structured across four primary segments: Biopharma, Diagnosis, Consumer Health, and Digital Healthcare. The Biopharma division specializes in the development and manufacturing of biological medications, including blood plasma derivatives and vaccines. The Diagnosis segment offers a range of services from clinical trials to specialized testing. The Consumer Health division provides products for daily wellness, such as health functional foods and injections. The Digital Healthcare unit delivers health services through a digital platform, aiming to provide more accessible care. The company focuses on innovation in drug development and expanding its role across the healthcare spectrum from treatment to diagnostics and preventative care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 3.8 KB
2025-12-16 00:00
기타경영사항(자율공시) (배당기준일 변경 안내)
Korean 5.2 KB
2025-08-29 00:00
주식등의대량보유상황보고서(일반)
Korean 212.2 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 4.6 MB
2025-06-26 00:00
투자설명서
Korean 4.8 MB
2025-06-26 00:00
증권발행실적보고서
Korean 54.8 KB
2025-06-25 00:00
[발행조건확정]증권신고서(채무증권)
Korean 15.4 KB
2025-06-20 00:00
[기재정정]증권신고서(채무증권)
Korean 5.5 MB
2025-06-20 00:00
[발행조건확정]증권신고서(채무증권)
Korean 612.7 KB
2025-06-19 00:00
타법인주식및출자증권취득결정
Korean 18.1 KB
2025-06-16 00:00
증권신고서(채무증권)
Korean 4.7 MB
2025-06-02 00:00
기업지배구조보고서공시
Korean 852.3 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 3.9 MB
2025-04-25 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 29.3 KB
2025-04-25 00:00
최대주주등소유주식변동신고서
Korean 92.4 KB

Automate Your Workflow. Get a real-time feed of all Green Cross Holdings filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Green Cross Holdings

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Green Cross Holdings via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.